Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France

Samira Fafi-Kremer; Timothee Bruel; Yoann Madec; Rebecca Grant; Laura Tondeur; Ludivine Grzelak; Isabelle Staropoli; Francois Anna; Philippe Souque; Catherine Mutter; Nicolas Collongues; Alexandre Bolle; Aurelie Velay; Nicolas Lefebvre; Marie Mielcarek; Nicolas Meyer; David Rey; Pierre Charneau; Bruno Hoen; Jerome De Seze; Olivier Schwartz; Arnaud Fontanet.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20101832

Documentos relacionados

  1. Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.
  2. Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021.
  3. Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020.
  4. Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients.
  5. The evaluation of a rapid microfluidic immunofluorescence antigen test in detecting the infectiousness of COVID-19 patients.
  6. Clinical evaluation of an automated, rapid mariPOC antigen test in screening of symptomatics and asymptomatics for SARS-CoV-2 infection.
  7. Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Intercollegiate Athletics Not Fully Mitigated With Daily Antigen Testing.
  8. Cell-based Culture Informs Infectivity and Safe De-Isolation Assessments in Patients with Coronavirus Disease 2019.
  9. Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration.
  10. Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5- and BA.5-XBB-convalescent subpopulations.